Pfizer-BioNTech cutting back vaccine deliveries to Canada due to production issues
OTTAWA — Global supply issues are temporarily delaying Canada’s vaccine shipment from Pfizer-BioNTech, but Procurement Minister Anita Anand says they will be made up with accelerated deliveries in February and March.
Anand said Friday that production issues in Europe will temporarily reduce promised doses to Canada, as well as all countries that receive vaccines from Pfizer’s European facility.
While the company assured Canada it will still be able to deliver four million doses by the end of March, Anand admitted that is no longer guaranteed.
“This is unfortunate. However such delays and issues are to be expected when global supply chains are stretched well beyond their limits,” Anand said at a news conference Friday.